RESEARCH-USE BIOSIMILAR ANTIBODY
Magrolimab
Monoclonal antibody · IgG4
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 antibody. Magrolimab, an IgG4 isotype, lacks ADCC function and exhibits relatively weak ADCP effector function. Magrolimab can be used for the study of malignant bone tumors and breast cancer.
TARGETIAP
YMonoclonal antibody
CATALOGSC-BS-401
CATALOG NUMBERSC-BS-401
MOLECULAR WEIGHTApprox. 145.73 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 antibody. Magrolimab, an IgG4 isotype, lacks ADCC function and exhibits relatively weak ADCP effector function. Magrolimab can be used for the study of malignant bone tumors and breast cancer.
Magrolimab is a recombinant research-use antibody directed against IAP.